Redefining the Druggable Proteome with Covalency Enabled Drug Discovery
Time: 9:30 am
day: Conference Day One
Details:
- Creating and identifying novel chemical probes to interrogate novel biology through the use of chemoproteomic platforms
- Discussing novel modalities shown to be accessible using covalent LMW ligands
- Elucidating the Novartis-Berkeley collaboration, its scope and learnings, to advance covalent drug discovery
